Home > Safety & Clinical Excellence > Webcasts > "Intensive Insulin Therapy: Has 'tight' control been redefined?"

Intensive Insulin Therapy: Has 'tight' control been redefined?

Achieving glucose control by using intensive insulin therapy has become a mainstay of therapy for intensive care patients. The publication of the NICE-SUGAR trial from Australia has added to the evidence to support the value of this intervention, but it also raised concern regarding its safe execution. This webcast reviews the Australian study and the impact the findings have had on the US practices. Target glucose levels in various patient populations will be discussed. Accuracy of glucose sampling and variation in applying various paper and computerized algorithms will be reviewed. Strategies for ICU nurses to deal with the increased workload, adjustment for concomitant therapies and react to changing patient conditions will be discussed. Examples of a multidisciplinary team approach to maintain glucose at target levels while avoiding hypoglycemia will be reviewed.

 

Objectives:

At the completion of this activity, participants should be able to:

  1. Analyze recent and ongoing evidence-based research interventions related to tight glucose control in the ICU.

  2. Describe optimal monitoring and assessment interventions associated with tight glucose control.

  3. Discuss the implications of failing to follow specific protocols as well as the impact of glucose timing and measurement inaccuracy.

  4. Cite the advantages of a multidisciplinary team approach to successful patient outcomes.


To access the program, go to: https://attewc.webex.com/attewc/lsr.php?AT=pb&SP=EC&rID=65293832&rKey=649D974BD4F55A2B

* Content including webcasts, continuing education, white papers and conference proceedings found in this section do not necessarily relate to CareFusion products.